The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Potential Risks to Stable Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Children With Cerebral X-linked Adrenoleukodystrophy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HLA-matched sibling donors are available for less than 20% of patients but historically have led to longer survival than that with HSCT from unrelated donors.”
From Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy (2024) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., Vidaud, M., Abel, U., Dal-Cortivo, L., Caccavelli, L., et al. (2009) · Science · doi:10.1126/science.1171242 · Cited by 1,508 · cited 2×
“Among the symptomatic patients, 11 of 18 (61%) survived, but only 1 was EFS (6%) (median [IQR] EFS time, 9 [3-22] months).”
Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy
Eichler, F., Duncan, C., Musolino, P. L., Orchard, P. J., De Oliveira, S., Thrasher, A. J., Armant, M., Dansereau, C., Lund, T. C., Miller, W. P., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1700554 · Cited by 604 · cited 2×
“Among the symptomatic patients, 11 of 18 (61%) survived, but only 1 was EFS (6%) (median [IQR] EFS time, 9 [3-22] months).”
Aubourg, P., Blanche, S., Jambaqué, I., Rocchiccioli, F., Kalifa, G., Naud-Saudreau, C., Rolland, M.-O., Debré, M., Chaussain, J.-L., Griscelli, C., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006283222607 · Cited by 366
Shapiro, E., Krivit, W., Lockman, L., Jambaqué, I., Peters, C., Cowan, M., Harris, R., Blanche, S., Bordigoni, P., Loes, D., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02629-5 · Cited by 329
Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy
Loes, D. J., Fatemi, A., Melhem, E. R., Gupte, N., Bezman, L., Moser, H. W., & Raymond, G. V. (2003) · Neurology · doi:10.1212/01.wnl.0000079050.91337.83 · Cited by 268
Berger, J., Wiesinger, C., & Eichler, F. (2015) · The Application of Clinical Genetics · doi:10.2147/tacg.s49590 · Cited by 140
Kemper, A. R., Brosco, J., Comeau, A. M., Green, N. S., Grosse, S. D., Jones, E., Kwon, J. M., Lam, W. K. K., Ojodu, J., Prosser, L. A., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.68 · Cited by 109
Haematopoietic stem cell transplantation in 12 patients with cerebral X-linked adrenoleukodystrophy
Baumann, M., Korenke, C., Weddige-Diedrichs, A., Wilichowski, E., Hunneman, D., Wilken, B., Brockmann, K., Klingebiel, T., Niethammer, D., Kühl, J., et al. (2003) · European Journal of Pediatrics · doi:10.1007/s00431-002-1097-3 · Cited by 47
Self-citation
Research works printed but not linked: 23
- Moser, 1997, Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy., Brain, 120, 1485, 10.1093/brain/120.8.1485 · DOI · Paper page
- Engelen, 2012, X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management., Orphanet J Rare Dis, 7, 51, 10.1186/1750-1172-7-51 · DOI · Paper page
- Turk, 2017, Therapeutic strategies in adrenoleukodystrophy., Wien Med Wochenschr, 167, 219, 10.1007/s10354-016-0534-2 · DOI
- Peters, 2004, Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999., Blood, 104, 881, 10.1182/blood-2003-10-3402 · DOI · Paper page
- Miller, 2011, Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report., Blood, 118, 1971, 10.1182/blood-2011-01-329235 · DOI · Paper page
- Beam, 2007, Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy., Biol Blood Marrow Transplant, 13, 665, 10.1016/j.bbmt.2007.01.082 · DOI · Paper page
- Mahmood, 2007, Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison study., Lancet Neurol, 6, 687, 10.1016/S1474-4422(07)70177-1 · DOI · Paper page
- Kato, 2016, Hematopoietic stem cell transplantation for inborn errors of metabolism: a report from the Research Committee on Transplantation for Inborn Errors of Metabolism of the Japanese Ministry of Health, Labour and Welfare and the Working Group of the Japan Society for Hematopoietic Cell Transplantation., Pediatr Transplant, 20, 203, 10.1111/petr.2016.20.issue-2 · DOI
- van den Broek, 2018, Early and late outcomes after cord blood transplantation for pediatric patients with inherited leukodystrophies., Blood Adv, 2, 49, 10.1182/bloodadvances.2017010645 · DOI
- Cartier, 2014, The role of microglia in human disease: therapeutic tool or target?, Acta Neuropathol, 128, 363, 10.1007/s00401-014-1330-y · DOI
- Moser, 2007, New insights about hematopoietic stem cell transplantation in adrenoleukodystrophy., Arch Neurol, 64, 631, 10.1001/archneur.64.5.631 · DOI
- Schönberger, 2007, Genotype and protein expression after bone marrow transplantation for adrenoleukodystrophy., Arch Neurol, 64, 651, 10.1001/archneur.64.5.noc60105 · DOI
- Capotondo, 2012, Brain conditioning is instrumental for successful microglia reconstitution following hematopoietic stem cell transplantation., Proc Natl Acad Sci U S A, 109, 15018, 10.1073/pnas.1205858109 · DOI · Paper page
- World Medical Association, 2013, World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects., JAMA, 310, 2191, 10.1001/jama.2013.281053 · DOI · Paper page
- Peters, 2003, Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines., Bone Marrow Transplant, 31, 229, 10.1038/sj.bmt.1703839 · DOI
- Przepiorka, 1995, 1994 Consensus conference on acute GVHD grading., Bone Marrow Transplant, 15, 825
- Shulman, 1980, Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients., Am J Med, 69, 204, 10.1016/0002-9343(80)90380-0 · DOI
- Loes, 1994, Adrenoleukodystrophy: a scoring method for brain MR observations., AJNR Am J Neuroradiol, 15, 1761
- Tran, 2017, Long-term outcome of patients with X-linked adrenoleukodystrophy: a retrospective cohort study., Eur J Paediatr Neurol, 21, 600, 10.1016/j.ejpn.2017.02.006 · DOI · Paper page
- Mitchell, 2013, Outcomes of hematopoietic stem cell transplantation in primary immunodeficiency: a report from the Australian and New Zealand Children’s Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry., Biol Blood Marrow Transplant, 19, 338, 10.1016/j.bbmt.2012.11.619 · DOI
- Fernandes, 2018, Haploidentical bone marrow transplantation with post transplant cyclophosphamide for patients with X-linked adrenoleukodystrophy: a suitable choice in an urgent situation., Bone Marrow Transplant, 53, 392, 10.1038/s41409-017-0015-2 · DOI
- Pierpont, 2017, Neurocognitive trajectory of boys who received a hematopoietic stem cell transplant at an early stage of childhood cerebral adrenoleukodystrophy., JAMA Neurol, 74, 710, 10.1001/jamaneurol.2017.0013 · DOI · Paper page
- Cartier, 2012, Lentiviral hematopoietic cell gene therapy for X-linked adrenoleukodystrophy., Methods Enzymol, 507, 187, 10.1016/B978-0-12-386509-0.00010-7 · DOI · Paper page
Cited by
Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy
Eichler, F., Duncan, C. N., Musolino, P. L., Lund, T. C., Gupta, A. O., De Oliveira, S., Thrasher, A. J., Aubourg, P., Kühl, J.-S., Loes, D. J., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2400442 · Cited by 107
Self-citationTreatment of cerebral adrenoleukodystrophy: allogeneic transplantation and lentiviral gene therapy
Gupta, A. O., Raymond, G., Pierpont, E. I., Kemp, S., McIvor, R. S., Rayannavar, A., Miller, B., Lund, T. C., & Orchard, P. J. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2124857 · Cited by 67
“The pattern of white matter involvement is varied, but often the splenium is the area where changes are first observed, and in about 70% of the cases the cerebral disease is primarily located in the occipital area (Figure 1) [33,34].”
BackgroundNeurocognitive benchmarks following transplant for emerging cerebral adrenoleukodystrophy
Pierpont, E. I., Nascene, D. R., Shanley, R., Kenney-Jung, D. L., Ziegler, R. S., Miller, W. P., Gupta, A. O., Lund, T. C., Orchard, P. J., & Eisengart, J. B. (2020) · Neurology · doi:10.1212/wnl.0000000000009929 · Cited by 21
Metadata
- Authors
- Kühl, J.-S., Kupper, J., Baqué, H., Ebell, W., Gärtner, J., Korenke, C., Spors, B., Steffen, I. G., Strauss, G., Voigt, S., Weschke, B., Weddige, A., Köhler, W., & Steinfeld, R.
- Affiliations
- Department of Pediatric Hematology/Oncology/Hemostaseology, University Hospital Leipzig, Leipzig, Germany
- Department of Pediatric Oncology/Hematology/SCT, Charité Campus Virchow-Klinikum, Berlin, Germany
- Department of Pediatric Neurology, Charité Campus Virchow-Klinikum, Berlin, Germany
- Department of Pediatric Neurology, University Medical Center Göttingen, Göttingen, Germany
- Department of Pediatric Neurology, Klinikum Oldenburg, Oldenburg, Germany
- Department of Pediatric Radiology, Charité Campus Virchow-Klinikum, Berlin, Germany
- Department of Pediatrics, Helios-Klinikum Berlin-Buch, Berlin, Germany
- Department of Neurology, University Hospital Leipzig, Leipzig, Germany
- Venue
- JAMA Network Open
- Publisher
- American Medical Association (AMA)
- Published
- 2018-07-20
- Volume
- 1
- Issue
- 3
- Pages
- e180769
- ISSN
- 2574-3805
- PMC
- PMC6324299
- Cited by
- 43
- References
- 8
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
